Defining benefit from lifestyle interventions during active surveillance

This publication has 12 references indexed in Scilit:

• An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial
  The Lancet Oncology, 2026
• Exercise oncology in prostate cancer: from observational insight to prescriptive precision
  British Journal of Cancer, 2025
• Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Cancer Active Lifestyle Study
  JNCI: Journal of the National Cancer Institute, 2025
• Effects of exercise during active surveillance for prostate cancer: A systematic review and meta-analysis
  Supportive Care in Cancer, 2024
• The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance
  Cancer, 2024
• Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial
  European Urology Oncology, 2023
• Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men’s Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])
  European Urology Focus, 2022
• A Randomized Trial of the Effects of Exercise on Anxiety, Fear of Cancer Progression and Quality of Life in Prostate Cancer Patients on Active Surveillance
  Journal of Urology, 2022
• Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS)
  Contemporary Clinical Trials, 2019
• Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance
  Urology, 2006